The DOI matches its Crossref record; 16 of the 19 references it cites were found in a registry or an index.
Isotonitazene Quantitation and Metabolite Discovery in Authentic Forensic Casework
Abstract
The synthetic opioid landscape continues to change as non-fentanyl-related substances appear in forensic toxicology casework. Among the newest synthetic opioids to emerge is isotonitazene, an analogue of a benzimidazole class of analgesic compounds. Isotonitazene is an active and potent synthetic opioid, but the extent to which this compound is causing toxicity among drug users was previously unknown. This report describes the confirmation and quantitation of isotonitazene in blood, urine and vitreous fluid through standard addition, as well as in vivo metabolic profile determination in drug users. Quantitative analysis was performed using liquid chromatography tandem mass spectrometry (LC–MS/MS), and metabolite discovery was performed using liquid chromatography quadrupole time-of-flight mass spectrometry (LC-QTOF-MS). In total, 18 cases were confirmed positive for isotonitazene, nine of which were previously negative for any opioid. The average isotonitazene concentration in blood was 2.2 ± 2.1 ng/mL (median 1.75 ng/mL, range 0.4–9.5 ng/mL), and the average isotonitazene concentration in urine was 2.4 ± 1.4 ng/mL (median 2.7 ng/mL, range 0.6–4.0 ng/mL). The lowest concentration of isotonitazene in blood was 0.4 ng/mL (two cases) with no other opioids present; findings in death investigations. Four metabolites of isotonitazene were detected in vivo. N- and O-dealkylation products were determined to be the most prominent urinary biomarkers, while 5-amino-isotonitazene was identified in most blood samples. The prevalence and popularity of isotonitazene continue to increase in the United States in early 2020. Toxicologists, medical examiners and coroners should be aware of novel opioids outside the standard scope of testing, especially in medicolegal death investigations. Forensic scientists should add isotonitazene to testing procedures, and public health officials should counsel about potent new drugs and the dangers of opioid use.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Calello et al. [25] and Amaducci et al. [42,43] reported reversal doses ranging from 0.08 mg to 2.00 mg”
From Nitazenes: review of comparative pharmacology and antagonist action (2025) · cites this paper as [25]
In the citing paper
“4‐Hydroxy nitazene has previously been hypothesised as a universal metabolite of nitazene analogues [8, 40].”
From Early identification of the use of potent benzylbenzimidazoles (nitazenes) through wastewater analysis: Two years of data from 22 countries (2025) · cites this paper as [8]
Citations
Cites
(2013) · Journal of Analytical Toxicology · doi:10.1093/jat/bkt054 · Cited by 873
Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review
Armenian, P., Vo, K. T., Barr-Walker, J., & Lynch, K. L. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.10.016 · Cited by 710
A review: Fentanyl and non-pharmaceutical fentanyls
Suzuki, J., & El-Haddad, S. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.11.033 · Cited by 445
Deaths Involving Fentanyl, Fentanyl Analogs, and U-47700 — 10 States, July–December 2016
O’Donnell, J. K., Halpin, J., Mattson, C. L., Goldberger, B. A., & Gladden, R. M. (2017) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6643e1 · Cited by 387
A systematic approach to standard addition methods in instrumental analysis
Bader, M. (1980) · Journal of Chemical Education · doi:10.1021/ed057p703 · Cited by 293
Drug Overdose Deaths in the United States, 1999-2015.
Hedegaard, H. B., Warner, M., & Miniño, A. (2017) · PubMed · Cited by 223
Mohr, A. L. A., Friscia, M., Papsun, D., Kacinko, S. L., Buzby, D., & Logan, B. K. (2016) · Journal of Analytical Toxicology · doi:10.1093/jat/bkw086 · Cited by 199
Self-citationThe Fentanyl Epidemic and Evolution of Fentanyl Analogs in the United States and the European Union
Jannetto, P. J., Helander, A., Garg, U., Janis, G. C., Goldberger, B., & Ketha, H. (2019) · Clinical Chemistry · doi:10.1373/clinchem.2017.281626 · Cited by 162
Blanckaert, P., Cannaert, A., Van Uytfanghe, K., Hulpia, F., Deconinck, E., Van Calenbergh, S., & Stove, C. (2020) · Drug Testing and Analysis · doi:10.1002/dta.2738 · Cited by 116
Synthese basisch substituierter, analgetisch wirksamer Benzimidazol-Derivate
Hunger, A., Kebrle, J., Rossi, A., & Hoffmann, K. J. (1957) · Cellular and Molecular Life Sciences · doi:10.1007/bf02161116 · Cited by 103
Research works printed but not linked: 4
- Drug Enforcement Administration, 2018, Schedules of Controlled Substances: Temporary Placement of Fentanyl-Related Substances in Schedule I
- Hoffmann, 1960, Benzimidazoles, United States Patent Office, 2, 935,514
- Krotulski, 2019, Isotonitazene
- Krotulski, 2019, Potent synthetic opioid—Isotonitazene—Recently identified in the Midwestern United States, NPS Discovery
Cited by
Vandeputte, M. M., Van Uytfanghe, K., Layle, N. K., St. Germaine, D. M., Iula, D. M., & Stove, C. P. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00064 · Cited by 161
DARK Classics in Chemical Neuroscience: Etonitazene and Related Benzimidazoles
Ujváry, I., Christie, R., Evans-Brown, M., Gallegos, A., Jorge, R., de Morais, J., & Sedefov, R. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00037 · Cited by 141
Walton, S. E., Krotulski, A. J., & Logan, B. K. (2022) · Journal of Analytical Toxicology · doi:10.1093/jat/bkab117 · Cited by 92
Self-citationKrotulski, A. J., Papsun, D. M., Walton, S. E., & Logan, B. K. (2021) · Drug Testing and Analysis · doi:10.1002/dta.3115 · Cited by 91
Self-citationMontanari, E., Madeo, G., Pichini, S., Busardò, F. P., & Carlier, J. (2022) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000970 · Cited by 89
Metadata
- Authors
- Krotulski, A. J., Papsun, D. M., Kacinko, S. L., & Logan, B. K.
- Affiliations
- Fredric Rieders Family Foundation (US)
- Toxicology Department, NMS Labs, 200 Welsh Rd, Horsham, PA 19044, USA
- Corresponding author
- Krotulski, Alex J
- Venue
- Journal of Analytical Toxicology
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-02-24
- Volume
- 44
- Issue
- 6
- Pages
- 521-530
- ISSN
- 0146-4760 (ISSN-L)
- 1945-2403
- OpenAlex
- W3008681705
- Semantic Scholar
- 448a39d2cd5a8a4e27357b13f5b56754e7582dcf
- Cited by
- 146
- References
- 19
- Citations by year
- 2026: 25 · 2025: 34 · 2024: 21 · 2023: 20 · 2022: 19 · 2021: 15 · 2020: 12
- FWCI
- 11.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Journal of Analytical Toxicology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Pathology and Forensic Medicine › Historical and Scientific Studies
- Keywords
- isotonitazene, synthetic opioids, opioid metabolites, dealkylation, urinary biomarkers, vitreous fluid, death investigation, drug users, new psychoactive substances
- MeSH terms
- Analgesics, Opioid, Benzimidazoles, Illicit Drugs, Designer Drugs, Substance Abuse Detection, Forensic Toxicology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Isotonitazene Quantitation and Metabolite Discovery in Authentic Forensic Casework. https://app.cochat.ai/papers/10.1093/jat/bkaa016
- The paper
- Krotulski, A. J., Papsun, D. M., Kacinko, S. L., & Logan, B. K. (2020). Isotonitazene Quantitation and Metabolite Discovery in Authentic Forensic Casework. Journal of Analytical Toxicology. https://doi.org/10.1093/jat/bkaa016
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.